Advanced Search
Current and Breaking News for Professionals, Consumers and Media



Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: John K. Jenkins, M.D., Director, Office of New Drugs, at FDA’s Center for Drug Evaluation and Research Last Updated: Jan 30, 2014 - 2:56:22 PM



Novel New Drug Approvals

By John K. Jenkins, M.D., Director, Office of New Drugs, at FDA’s Center for Drug Evaluation and Research
Jan 30, 2014 - 2:52:42 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page

(HealthNewsDigest.com) - Last year marked another strong year for FDA approvals of novel new drugs, known as new molecular entities (NMEs). In 2013, FDA's Center for Drug Evaluation and Research (CDER) approved 27 NMEs last year - about the same as the 26 average NME approvals per year since the beginning of this decade.

More important than the quantity of novel new drugs approved in 2013 is theirquality - and the important new roles many of these drugs can serve in advancing medical care and the health of patients. We now have new safe and effective treatments for a wide range of serious medical conditions, such as late-stage breast cancer, chronic hepatitis C, metastatic melanoma, mantle cell lymphoma, chronic lymphocytic leukemia, homozygous familial hypercholesterolemia, pulmonary arterial hypertension, and many more. Some of these medications offer new hope to patients who previously had few or no treatment options.

Read the entire blog at FDA Voice.

###

For advertising and promotion on HealthNewsDigest.com, call Mike McCurdy: 877-634-9180 or [email protected] We have over 7,000 journalists as subscribers.

 



Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Approves Zydelig for Three Types of Blood Cancers
+ Alere Receives FDA Clearance for Alere™ i Influenza A and B Test First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes
+ BioDelivery Sciences Receives FDA Approval for BUNAVAIL(TM) (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence
+ GenomeTrakr Helps FDA Identify Dangerous Bacteria
+ FDA Approves First Generic Versions of Celecoxib
+ FDA Allows Marketing of First Non-invasive Test to Help in Identifying Cause of Certain Kidney Disease
+ Trimel Receives FDA Approval for Natesto™ Nasal Gel to Treat Men with Low Testosterone
+ Harnessing the Power of Databases to Evaluate Medical Products
+ FDA Approves Drug-Free Treatment CEFALY® for Migraine Prevention
+ FDA Opens Review of Rules for Over-the-Counter Drugs, Including Acetaminophen



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions